Nanomedical Diagnostics, a Serra Capital II portfolio company, was featured on news.gnom.es on October 13. Nanomedical Diagnostics is a biotech company developing and commercializing bioelectronics for use in research and diagnostics. The company announced the completion of a Series A financing round of $1.6 million, which was led by Serra Ventures.
Tim Hoerr, CEO of Serra Ventures, was quoted enthusing “This company is applying a very novel and powerful technology to a current hot issue– personalized healthcare. Nanomed has a bold, expansive vision, but the team has built interim products and revenue opportunities on the road to their end goal of putting information in people’s hands to make educated health choices.”